Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key
Biotech stocks have delivered sizzling returns over the last few years. New drugs have improved the lives of patients and made big profits for investors in the process. Creating or licensing a one-of-a-kind drug creates an opportunity that even the greenest investor can understand. This is part of why the biotechnology industry is full of optimism, from both management and investors. And clinical-stage biotech stocks could present immense potential.
3 Biotech Stocks To Watch In September
The cancer medicine industry runs into hundreds of billions of dollars in terms of value. Therefore, it may be worthwhile to look at cancer-related stocks. There could be considerable value if some companies manage to execute all their plans correctly. On that note, here is a look at three cancer-related stocks.
Target (TGT) Stock Price Hits All-Time High: Time To Sell Or Hold?
In recent years Target Corporation (TGT Stock Report ) stock has attracted divided opinion from both bears and bulls. Bulls have held the sentiment size of Target and digital transformation will help Target maintain a competitive edge in the market. Bears, on the other hand, had warned that the company will struggle and play catch up to Walmart Inc. (WMT Stock Report ) and Amazon.com Inc. (AMZN Stock Report )